Encoded Therapeutics is a biotechnology company combining the precision of gene regulation with the versatility of gene therapies to create breakthrough treatments for individuals living with severe genetic diseases. For more information, please visit (url removed).

Reporting to the VP Medical Affairs, the Senior Director, Global HEOR and Evidence Generation is a senior member of the Medical and Patient Affairs (MPA) team who will serve as a critical cross-functional bridge to support regulatory and commercial evidence generation needs. This individual will be the primary architect and owner of the HEOR and value evidence strategy for ETX101, the first gene therapy for Dravet syndrome.

ETX101 is a single-administration, potentially transformative intervention. As such, this individual understands global evidence needs and will be responsible for developing a sophisticated, long-term value evidence package for global stakeholders, and for designing and implementi...